Dag Rune Stormoen
6PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 03, 2025
An example of drug repurposing: ebastine in combination with docetaxel as a treatment for metastatic castration-resistant prostate cancer-the EXUROC prostate study, a clinical trial protocol.Katrine Ørum, Dag R Stormoen, Jakob Lauritsen
|Jan 05, 2024
Glomerular filtration rate measurement during platinum treatment for urothelial carcinoma: optimal methods for clinical practice.Dag Rune Stormoen, Ulla Nordström Joensen, Gedske Daugaard
|Nov 22, 2023
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer.Yuzhen Zhou, Judit Börcsök, Elio Adib
|Apr 18, 2023
Association of patient-reported pain with survival in bladder cancer: a post-hoc analysis of the iBLAD trial.Dag Rune Stormoen, Gry Assam Taarnhøj, Rasmus Blechingberg Friis
|May 05, 2021
Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer.Judit Börcsök, Miklos Diossy, Zsofia Sztupinszki
|Mar 01, 2021
Patient reported outcomes interfering with daily activities in prostate cancer patients receiving antineoplastic treatment.Dag Rune Stormoen, Christina Baeksted, Gry Assam Taarnhøj
Pageof 1
Frequent Collaborators
3 joint publications
Helle Pappot
2 joint publications
Judit Börcsök
2 joint publications
Zsofia Sztupinszki
2 joint publications
Zoltan Szallasi
2 joint publications
Gry Assam Taarnhøj
1 joint publications
Miklos Diossy
1 joint publications
Sandor Spisak
1 joint publications
Istvan Csabai
1 joint publications
Katrine Ørum
1 joint publications
Jakob Lauritsen
